Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FNKQC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,349
Award facts
- Contract value 100% obligated
- $3,349.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,349.17 by the Defense Logistics Agency on September 9, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is not set-aside and was competitively awarded with a firm fixed price structure and an ultimate completion date of September 10, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
The delivery order exemplifies AmerisourceBergen's critical role in the federal medical supply chain, particularly for supporting Defense Health Agency and military healthcare systems with specialized pharmaceutical products. Repatha is a PCSK9 inhibitor indicated for the treatment of high cholesterol and represents the type of specialized medication included within the company's expansive portfolio of brand-name drugs, biologics, and medical supplies available through the DLA Troop Support Medical contract. AmerisourceBergen's consistent receipt of non-set-aside, competitively awarded contracts demonstrates its established capability to meet rigorous federal procurement standards for pharmaceutical distribution and logistics.
Quick answers
Who was awarded contract SPE2DB25FNKQC?
SPE2DB25FNKQC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FNKQC worth?
The government has obligated $3,349 on SPE2DB25FNKQC.
Is contract SPE2DB25FNKQC an order under another contract?
Yes. SPE2DB25FNKQC is a delivery order under SPE2DB20D1004, an indefinite delivery contract.
Was contract SPE2DB25FNKQC competed?
The extent of competition for SPE2DB25FNKQC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award